Table 1.

Ras Point Mutations in MM

First Author N12 N13 N61 K12 K13 K61Total
Neri, patients at diagnosis244  2  9  2  1  0  12/43  
Neri, patients at relapse244  0  1  3  2  0  0  6/13 
Matozaki247  2  3  2     4/13 
Portier246  4  1  4  3  0  14/30  
Tanaka245  1  2  2  0  0  5/10  
Paquette248    2     2/17 
Corradini243  2  1  7  1  0  11/90  
Yasuga249  0      2/45  
Liu250  6/129  5/129 50/346  16/139  7/139   63/160  
Total  17/373 15/328  81/607  24/325  8/325  3/186  
 4.5% 4.6%  13.3%  7.4%  2.5%  1.6%  34% 
First Author N12 N13 N61 K12 K13 K61Total
Neri, patients at diagnosis244  2  9  2  1  0  12/43  
Neri, patients at relapse244  0  1  3  2  0  0  6/13 
Matozaki247  2  3  2     4/13 
Portier246  4  1  4  3  0  14/30  
Tanaka245  1  2  2  0  0  5/10  
Paquette248    2     2/17 
Corradini243  2  1  7  1  0  11/90  
Yasuga249  0      2/45  
Liu250  6/129  5/129 50/346  16/139  7/139   63/160  
Total  17/373 15/328  81/607  24/325  8/325  3/186  
 4.5% 4.6%  13.3%  7.4%  2.5%  1.6%  34% 

The number of mutations of N-ras codon 12 (N12), codon 13 (N13), and codon 61 (N61), and of K-ras codon 12 (K12), codon 13 (K13), and codon 61 (K61) detected in MM patients in various studies is summarized.

or Create an Account

Close Modal
Close Modal